Goldman Sachs Group Inc Qiagen N.V. Call Options Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	SELL	$35.55 - $43.57 $1.78 Million - $2.18 Million	-50,000 Reduced 50.0%	50,000 $2.17 Million
Q3 2023 May 14, 2024	BUY	$39.13 - $47.24 $1.96 Million - $2.36 Million	50,000 Added 100.0%	100,000 $4.05 Million
Q1 2023 May 14, 2024	SELL	$45.29 - $50.76 $6.79 Million - $7.61 Million	-150,000 Reduced 60.0%	100,000 $4.59 Million
Q1 2023 May 11, 2023	BUY	$45.29 - $50.76 $4.53 Million - $5.08 Million	100,000 New	100,000 $4.59 Million
Q3 2022 May 14, 2024	BUY	$40.9 - $50.42 $6.14 Million - $7.56 Million	150,000 Added 150.0%	250,000 $10.3 Million
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $6.14 Million - $7.56 Million	150,000 Added 150.0%	250,000 $10.3 Million
Q2 2022 May 14, 2024	BUY	$42.98 - $49.77 $2.15 Million - $2.49 Million	50,000 Added 100.0%	100,000 $4.72 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $26.9 Million - $31.2 Million	-626,300 Reduced 86.23%	100,000 $4.72 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $30.7 Million - $39.4 Million	726,300 New	726,300 $35.6 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.8B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.